We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.55 | -5.28% | 45.75 | 45.50 | 46.00 | 50.50 | 45.50 | 50.50 | 5,719,956 | 16:29:57 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.31 | 129.75M |
From May 2019 to May 2024
TIDMAVCT
RNS Number : 3774A
Avacta Group PLC
22 December 2014
Avacta Group plc
("Avacta" or the "Group")
Posting of Annual Report & Accounts and AGM Notice
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, confirms that the Annual Report and Accounts for the year ended 31 July 2014, the Notice of the Annual General Meeting and a Form of Proxy were posted to shareholders on 19 December 2014.
The Annual General Meeting is to be held on 23 January 2015 at 2.00pm at the offices of Walker Morris, Kings Court, 12 King Street, Leeds, LS1 2HL.
A copy of the Annual Report & Accounts and Notice of Annual General Meeting is available on the Company's website: www.avacta.com.
Enquiries:
Avacta Group plc Tel: +44 (0) 844 414 Alastair Smith, Chief Executive Officer 0452 Tim Sykes, Chief Financial Officer www.avacta.com Numis Securities Limited Tel: +44 (0) 207 260 Michael Meade / Freddie Barnfield - Nominated 1000 Adviser www.numiscorp.com James Black - Corporate Broking Media Enquiries Tel: +44 (0) 207 933 Walbrook PR Ltd 8780 Anna Dunphy / Mike Wort avacta@walbrookpr.com
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:
Hot Features
Premium
Avacta Analytical High throughput analysis instrument, Optim,
www.avactaanalytical.com to help reduce the cost and risk of drug development.
--------------------------------------- -------------------------------------------------------
Avacta Animal Health Veterinary diagnostics reference laboratory
www.avactaanimalhealth.com and diagnostic kit provider.
--------------------------------------- -------------------------------------------------------
Avacta Life Sciences Novel non-antibody affinity reagents called
www.avactalifesciences.com Affimers, with a wide range of Life Science
applications in diagnostics, drug and biomarker
discover and biotech research and development.
--------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBLBDDLUBBGSC
1 Year Avacta Chart |
1 Month Avacta Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
